Spring Bank Pharmaceuticals, Inc. (39)

Browse by Contract Category

Contracts

Amendment No. 1 to Agreement and Plan of Merger, dated November 20, 2022 (Filed With SEC on November 21, 2022)
Employment Agreement Amendment, dated April 6, 2022 by and between F-star Therapeutics, Inc and Louis Kayitalire M.D (Filed With SEC on May 10, 2022)
Service Agreement Amendment, dated April 6, 2022 by and between F-star Therapeutics Ltd and Neil Brewis, Ph.D (Filed With SEC on May 10, 2022)
Description of Registered Securities (Filed With SEC on March 15, 2022)
License Agreement between F-star Therapeutics, Inc. and Astrazeneca AB, dated as of July7, 2021 (Filed With SEC on November 10, 2021)
Side Letter, dated June 30, 2021, to (a) the License and Collaboration Agreement, dated August 24, 2016, by and among BBB Holding Ltd (f/k/a F-star Gamma Limited, DBH ), F-star... (Filed With SEC on August 13, 2021)
Lease Agreement between Are-Tech Square, LLC and F-star Biotechnology Ltd., dated December 31, 2018 (Filed With SEC on March 30, 2021)
Agreement and Plan of Merger, dated June 22, 2022, by and among invoX Pharma Limited, Fennec Acquisition Incorporated, Sino Biopharmaceutical Limited and F-star Therapeutics, Inc (Filed With SEC on June 23, 2022)
Addendum to the Indefinite-Term Employment Contract, dated as of June 25, 2021, by and between F-star Therapeutics, Inc. and Louis Kayitalire (Filed With SEC on May 10, 2022)
Consulting Agreement Amendment, dated April 6, 2022 by and between F-star Therapeutics, Inc and Darlene Deptula-Hicks (Filed With SEC on May 10, 2022)
Executive Service Agreement Amendment, dated as of April 6, 2022 by and between F-star Therapeutics Ltd and Eliot Forster, Ph.D (Filed With SEC on May 10, 2022)
Form of Option Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 15, 2022)
Consulting Agreement, dated as of August 1, 2021, by and between F-star Therapeutics LLC and Darlene Deptula-Hicks (Filed With SEC on March 15, 2022)
Form of Performance Share Unit Grant Notice and Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 15, 2022)
Form of Restricted Share Grant Notice and Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 15, 2022)
Form of Restricted Share Unit Grant Notice and Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 15, 2022)
Venture Loan and Security Agreement, dated April 1, 2021, by and among F-star Therapeutics, Inc., as borrower, F-star Therapeutics Limited, as guarantor, and Horizon Technology... (Filed With SEC on May 17, 2021)
Form of Warrant issued under the Venture Loan and Security Agreement, dated April 1, 2021 (Filed With SEC on May 17, 2021)
Underwriting Agreement, dated May 6, 2021, between F-star Therapeutics, Inc. and SVB Leerink LLC (Filed With SEC on May 10, 2021)
Tenancy Agreement between Babraham Bioscience Technologies Limited and F-star Biotechnology Limited, dated February 14, 2018 (Filed With SEC on March 30, 2021)
Non-Employee Director Compensation Policy (Filed With SEC on March 30, 2021)
Executive Service Agreement, dated as of October 1, 2018, as amended July 22, 2020, by and between F-star Biotechnology Limited and Eliot Forster, Ph.D (Filed With SEC on November 20, 2020)
STING Antagonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare... (Filed With SEC on November 20, 2020)
STING Agonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare Inc.,... (Filed With SEC on November 20, 2020)
Form of Indemnification Agreement, by and between F-star Therapeutics, Inc. and each of its directors and executive officers (Filed With SEC on November 20, 2020)
Employment Agreement, dated as of July 24, 2020, by and between F-star Therapeutics LLC and Louis Kayitalire, M.D (Filed With SEC on November 20, 2020)
Service Agreement, dated as of July 23, 2020, by and between F-star Biotechnology Limited and Neil Brewis, Ph.D (Filed With SEC on November 20, 2020)
Consulting Agreement, dated as of May 1, 2019, by and between F-star Therapeutics LLC and Darlene Deptula-Hicks (Filed With SEC on November 20, 2020)
SPRING BANK PHARMACEUTICALS, INC. RETENTION AND BONUS AWARD AGREEMENT (Filed With SEC on November 3, 2020)
SPRING BANK PHARMACEUTICALS, INC. RETENTION AND BONUS AWARD AGREEMENT (Filed With SEC on November 3, 2020)
Spring Bank Pharmaceuticals, Inc. Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 25, 2020)
Form of Retention Agreement (Filed With SEC on May 7, 2020)
Form of Restricted Stock Unit Agreement (Filed With SEC on May 7, 2020)
Pay-Off Letter, dated April 8, 2020 (Filed With SEC on April 13, 2020)
Form of Amended and Restated Warrant (Filed With SEC on April 13, 2020)
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 14, 2020)
Loan and Security Agreement, dated September 3, 2019 (Filed With SEC on September 4, 2019)
Amended and Restated Non-Employee Director Compensation Policy, effective January 1, 2019 (Filed With SEC on March 11, 2019)
Form of Performance-Based Restricted Stock Unit Agreement under 2015 Stock Incentive Plan (Filed With SEC on March 11, 2019)